Sélectionner une page
Logo Company

Synapcell

Corinne ROUCARD

CEO

Who are we?

SYNAPCELL is a preclinical stage biotechnology company focused on Central Nervous System (CNS) disorders. Since 2005, our CRO activity supports international pharmaceutical companies in revealing the therapeutic potential of their compounds in development. Backed by intensive Research and Development programs, we developed Cue®, a predictive decision-making solution that comes with a large set of assays designed for Drug Discovery applications. Cue® uses the power and sensitivity of Electro-Encephalography (EEG) to identify functional biomarkers of neurological diseases in vivo, with remarkable human translatability. Our returning customers in USA, Japan, Korea or Europe helped the company establish a unique reputation on the market and is the basis for long-lasting successful business partnerships.